Literature DB >> 2891428

Migraine.

J G Edmeads1.   

Abstract

Recent advances in migraine therapy include the recognition of analgesic or ergotamine abuse as a cause of chronic daily migraine, the introduction of effective non-narcotic drugs such as chlorpromazine, dihydroergotamine and corticosteroids for the treatment of intractable migraine attacks, the increased number of beta-blockers now recognized as effective prophylactic agents and the introduction of calcium-channel blockers for prophylaxis. There is a sufficient variety of antimigraine drugs, and therapy should be successful for most sufferers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2891428      PMCID: PMC1267535     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  30 in total

1.  Alterations in response to somatic pain associated with anaesthesia. II. The effect of thiopentone and pentobarbitone.

Authors:  J W DUNDEE
Journal:  Br J Anaesth       Date:  1960-09       Impact factor: 9.166

2.  The treatment of chronic pain with psychotropic drugs.

Authors:  H Merskey; R A Hester
Journal:  Postgrad Med J       Date:  1972-10       Impact factor: 2.401

3.  Ergotamine induced headaches in migrainous patients.

Authors:  A R Rowsell; C Neylan; M Wilkinson
Journal:  Headache       Date:  1973-07       Impact factor: 5.887

4.  Psychiatric adverse reactions to methysergide.

Authors:  I Persyko
Journal:  J Nerv Ment Dis       Date:  1972-04       Impact factor: 2.254

5.  The prophylactic value of propranolol in angina pectoris.

Authors:  R Rabkin; D P Stables; N W Levin; M M Suzman
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

6.  The treatment of angina pectoris with coexistent migraine.

Authors:  P Wykes
Journal:  Practitioner       Date:  1968-05

7.  Nadolol and propranolol in migraine management.

Authors:  B Olerud; C L Gustavsson; B Furberg
Journal:  Headache       Date:  1986-11       Impact factor: 5.887

8.  Long-acting propranolol in the prophylaxis of migraine.

Authors:  S Diamond; G D Solomon; F G Freitag; N D Mehta
Journal:  Headache       Date:  1987-02       Impact factor: 5.887

9.  Transformed or evolutive migraine.

Authors:  N T Mathew; U Reuveni; F Perez
Journal:  Headache       Date:  1987-02       Impact factor: 5.887

10.  Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial.

Authors:  J D Gomersall; A Stuart
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

View more
  2 in total

1.  New Prescriptions for Migraine in the Emergency Department: Treating a common affliction and presenting symptom.

Authors:  P L Lane
Journal:  Can Fam Physician       Date:  1992-06       Impact factor: 3.275

2.  Migraine Prophylaxis: A pharmacologic approach.

Authors:  I Danys
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.